385 related articles for article (PubMed ID: 24901010)
1. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
[TBL] [Abstract][Full Text] [Related]
2. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
4. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
6. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
Ramírez E; Bellón T; Tong HY; Borobia AM; de Abajo FJ; Lerma V; Moreno Hidalgo MA; Castañer JL; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Cachafeiro L; González-Herrada C; González O; Aramburu JA; Laosa O; Hernández R; Carcas AJ; Frías J
Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of cutaneous adverse drug reactions.
Aihara M
J Dermatol; 2011 Mar; 38(3):246-54. PubMed ID: 21342226
[TBL] [Abstract][Full Text] [Related]
8. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
[TBL] [Abstract][Full Text] [Related]
9. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
Borroni RG
G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
[TBL] [Abstract][Full Text] [Related]
11. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
[TBL] [Abstract][Full Text] [Related]
12. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
13. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children.
Manuyakorn W; Likkasittipan P; Wattanapokayakit S; Suvichapanich S; Inunchot W; Wichukchinda N; Khongkhatithuml C; Thampratankul L; Kamchaisatian W; Benjaponpitak S; Mahasirimongkol S
Epilepsy Res; 2020 May; 162():106321. PubMed ID: 32272329
[TBL] [Abstract][Full Text] [Related]
15. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
Pirmohamed M; Ostrov DA; Park BK
J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
[TBL] [Abstract][Full Text] [Related]
16. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
Michels AW; Ostrov DA
J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
[TBL] [Abstract][Full Text] [Related]
18. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
Yeo SI
Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
[TBL] [Abstract][Full Text] [Related]
19. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]